ANTIMALARIAL DRUGS AND BURKITT'S LYMPHOMA

J. N. P. Davies; Peter J Barnes; R B McGucken

doi:10.1016/s0140-6736(74)93070-0

Back

Shared by

Peter J Barnes

Imperial College London

ANTIMALARIAL DRUGS AND BURKITT'S LYMPHOMA

Article 1974 en

Related publications

Article2000

Burkitt's lymphoma in Greek adults

Theofanis Economopoulos, Meletios A Dimopoulos, Andreas Foudoulakis, Christos Nikolaidis, C. Tsatalas, D. Pectacides, Dimitra Rontogianni, E. Papageorgiou, George Fountzilas

Chapter in a book2020

High Dose Therapy (HDT) in Burkitt’s Lymphoma

Didier Frappaz, ,

Authors

JD
J. N. P. Davies
Peter J Barnes
Imperial College London
RM
R B McGucken

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Jean Yves Blay

Éric Bouffet,

M Brunat-Mentigny,

T Philip

Article2007

Cardiotoxicity of antimalarial drugs

Sir Nicholas White

The Lancet Infectious Diseases

Article1985

Clinical Pharmacokinetics of Antimalarial Drugs

Sir Nicholas White

Clinical Pharmacokinetics

Article2007

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs

Ric N. Price, Grant Dorsey, Elizabeth A. Ashley, Karen I. Barnes, J. Kevin Baird, Umberto D’Alessandro, Philippe J. Guérin, Miriam K. Laufer, Inbarani Naidoo, François Nosten, Piero Olliaro, Christopher V. Plowe, Pascal Ringwald, Carol Hopkins Sibley, Kasia Stepniewska, Sir Nicholas White

Malaria Journal